Delisting risk
enVVeno Medical (NVNO)
Develops a catheter-delivered tissue valve for severe deep chronic venous insufficiency.
$11.40
At close+0.42 (+3.83%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions17 holders · as of Mar 31, 2026 | 14.72% | 100.5K shares | |
| Insiders5 holders · as of Jun 12, 2026 | 1.43% | 9.8K shares | |
| Otherremainder | 83.85% | 572.4K shares |
682.7K company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Two share counts disagree (682.7K in the company's Sep 3, 2026 report, 16.5K elsewhere); stakes use the report.
A stock split fell inside the quarter, so quarter-on-quarter changes are not shown.
Institutions13F, as of Mar 31, 2026
17 holders · 100.5K shares
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Kingdon Capital Management, L.L.C. | 36.2K | 5.30% | May 15, 2026 | |
| CM Management, LLC | 35.7K | 5.23% | May 8, 2026 | |
| Geode Capital Management, LLC | 10.5K | 1.53% | May 15, 2026 | |
| Vanguard Capital Management LLC | 6.3K | 0.92% | May 15, 2026 | |
| JPMorgan Chase & Co | 5.2K | 0.76% | May 13, 2026 | |
| Vanguard Fiduciary Trust Co | 2.2K | 0.32% | May 8, 2026 | |
| BlackRock, Inc. | 1.8K | 0.27% | May 13, 2026 | |
| Westside Investment Management, Inc. | 1.6K | 0.23% | May 4, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Perceptive Advisors LLC | 9.99% | 13G | May 15, 2026 ↗ | |
| Thomas A. Satterfield, Jr. | 9.00% | 13G | Nov 19, 2025 ↗ | |
| Kingdon Capital Management, L.L.C. | 7.10% | 13G | Sep 9, 2025 ↗ | |
| Braeden Lichtiincl. Northstrive Fund II LP | 5.05% | 13D | Feb 20, 2026 ↗ |
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jun 11, 2026 | Francis Duhaydirector | Sale | 140 | $10.31 | 2,362 |
| Mar 12, 2026 | Francis Duhaydirector | Sale | 140 | $11.52 | 2,502 |
| Dec 11, 2025 | Francis Duhaydirector | Sale | 4,900 | $0.3556 | 92,544 |
| Sep 15, 2025 | Francis Duhaydirector | Sale | 4,900 | $0.8300 | 97,444 |
CongressHouse and Senate disclosures
Not reported.
